Abstract
Nicergoline is a hemisynthetic derivative of ergot alcaloids, which has been shown to have a predominant alpha-1 blocking activity with a slight activity on alpha-2 receptors [8, 15]. This alpha-blocking and, therefore, vasodilating effect has justified the study of the vascular effects of the drug in healthy subjects and in patients with peripheral arterial disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boismare F, Lefraneois J (1980) Haemodynamic effects of nicergoline in man at rest and during exercise. Clin Exp Pharmacol Physiol 7: 105–112
Boismare F, Philippe JC, Leduc X (1974) Etude rhéographique de l’effet de la nicergoline sur la circulation des membres inférieurs chez le sujet sain et chez l’artéritique. Thérapie 29: 925–932
Boismare F, Lefraneois J, Leclerc JL, Moore N, Paux G (1979) Influence du décubitus sur l’hémodynamique du sujet sain, traité ou non par la nicergoline. J Pharmacol 10: 455–460
Boismare F, Leclerc JL, Lefraneois J, Moore N, Paux G, Schrub JC, Vuillermet P (1981) Effets hémodynamiques et métaboliques de l’épreuve d’effort chez l’artéritique diabétique traité ou non par la nicergoline. Sem Hôp Paris 57: 1455–1457
Branchereau A, Sicardi F (1977) Recherche d’un effet antiaggrégant plaquettaire en pathologie artérielle; essai d’un alpha-bloquant, la nicergoline. Méditerr Méd 135: 43–46
DerAgopian P, Rosa A, Gautier JC, Lhermitte F (1973) Thromboses expérimentales: effets d’un alpha-bloquant, la nicergoline. Nouv Press Med 2: 2521–2524
Denniston JC (1976) Measurement of cardiac output by electrical impedance at rest and during exercise. J Appl Physiol 40: 91–95
Huchet AM, Mouille P, Chelly J, Lucet B, Doursout MF, Lechat P, Schmitt H (1981) Effects of nicergoline on the cardiovascular system of dogs and rats. J Cardiovasc Pharmacol 3: 677–691
Judy WV (1969) Comparative evaluation of the thoracic impedance and isotope dilution methods for measuring cardiac output. Aerospace Med 40: 532
Kubicek WG (1966) Development and evaluation of an impedance cardiac output system. Aerospace Med 37: 1208
Lagarde M, Guichardant M, Ghazi I, Dechavanne M (1980) Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospolipids. Prostaglandins 19: 551–557
Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60: 481–497
Lemenn R, Migne J, Prost-Dvojakovic RJ (1977) Etude ultrastructurale de l’action d’un anti-aggrégant sur les plaquettes sanguines: application à la nicergoline. Thérapie 32: 205–214
Migne J, Saint-Maurice JP, Santonja R, Kunz S (1974) Activité anti-aggrégante plaquet- taire: effets d’un alpha-bloqueur, la nicergoline. Sem Hôp Paris 50: 649–655
Moore ND, Cazor JL, Leclerc JL, Saligaut C, Boismare F (1981) Some haemodynamie effects of nicergoline, a new alpha-blocking agent, in the closed-chest anaesthetized dog as compared with nitroprusside and nitroglycerin. Arzneimittelforsch/Drug Res 31: 10, 1693–1698
Praga C, PogUani E (1971) Effect of nicergoline (F 6714) on human platelet aggregation in vitro. Acta Med Scand [Suppl] 519: 263–266
Praga C, Tantalo Y, Marangoni R (1979) Nicergoline and platelet aggregation: a review of experimental and clinical studies. Arzneimittelforsch/Drug Res 29: 1270–1277
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Boismare, F., Moore, N. (1986). Haemodynamic and Metabolic Effects of Nicergoline in Healthy and Arteritic Patients at Rest or During Exercise. In: Heidrich, H. (eds) Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70786-5_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-70786-5_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-15901-8
Online ISBN: 978-3-642-70786-5
eBook Packages: Springer Book Archive